Suzhou Yangen Biotech Co., Ltd takes technological innovation as its core driving force, conducts process innovation through technologies such as asymmetric metal-catalyzed hydrogenation, bio-enzyme catalysis, and flow chemistry, and can provide products including DPPC/DMPC/Bis(2,2,6,6-tetramethyl-1-piperidinyloxy-4-yl) sebacate.